Hyderabad-based Dr Reddy’s Laboratories has reportedly expressed interest in acquiring the Novartis parent’s stake, which is valued at nearly Rs 1,805 crore at the current market price
There can be no assurance that the strategic review of Novartis India Ltd will be completed in 2024, or that the outcome would result in the implementation of any transaction, it said.
The board of directors of Novartis India took note of the communication received from Novartis AG, holding company and promoter, regarding their intention to conduct a strategic review to unlock the value of their shareholding in the .
Board Of Novartis India To Support Promoter In Strategic Review menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.